Despite clonal evolution, including driver mutation presence in genes such as NOTCH1 or SF3B1, observed in indolent CLL cases, there was no clinical evidence of disease activity during long-term follow-up after sampling. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.